Medicine
Methocarbamol 500 mg tablet
Methocarbamol 500 mg tablet is a generic prescription medicine for oral use, made by 42 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature, between 20°C and 25°C (68°F and 77°F).
Key facts
- Active ingredient (INN)
- Methocarbamol
- Brand
- Sold under the generic name
- Strength
- 500 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 24 tablets, 100 tablets, 500 tablets and 358 more
- Manufacturers
- Granules IndiaIndiaCamber PharmaceuticalsIndiaAurobindo PharmaIndiaUnichem LaboratoriesIndiaDoc RxOxford PharmaceuticalsBostalGranulation TechnologySolco HealthcareXLCare Pharmaceuticals42 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature, between 20°C and 25°C (68°F and 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- M03BA03 Methocarbamol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 January 1982
- Identifiers
- RxCUI 197943, 197944, 2611794DailyMed set ID 943fe701-5d7d-4abe-a529-c5a548e94bc6, 0deb5368-ffdc-40fc-a97c-ba89b7a97e50, 4de118fe-bd8e-6cc4-e063-6394a90a1320 +37NDC 72789-021, 72789-397, 80425-0579 +37Application ANDA208507, ANDA040489, ANDA209312 +7
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 42 labelers. The register lists 361 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 24 tablet, coated in 1 bottle | 62207-754-41 | Granules IndiaIndia | 15 May 2018 |
| 100 tablet, coated in 1 bottle | 62207-754-43 | Granules IndiaIndia | 15 May 2018 |
| 500 tablet, coated in 1 bottle | 62207-754-47 | Granules IndiaIndia | 15 May 2018 |
| 1000 tablet, coated in 1 bottle | 62207-754-49 | Granules IndiaIndia | 15 May 2018 |
| 100 tablet, coated in 1 bottle | 70010-754-01 | Granules IndiaIndia | 1 February 2020 |
| 500 tablet, coated in 1 bottle | 70010-754-05 | Granules IndiaIndia | 1 February 2020 |
| 1000 tablet, coated in 1 bottle | 70010-754-10 | Granules IndiaIndia | 1 February 2020 |
| 24 tablet, coated in 1 bottle | 70010-754-35 | Granules IndiaIndia | 1 February 2020 |
| 100 tablet, film coated in 1 bottle | 59651-340-01 | Aurobindo PharmaIndia | 9 February 2023 |
| 500 tablet, film coated in 1 bottle | 59651-340-05 | Aurobindo PharmaIndia | 9 February 2023 |
| 12 bottle in 1 case / 100 tablet in 1 bottle | 31722-533-01 | Camber PharmaceuticalsIndia | 20 March 2013 |
| 12 bottle in 1 case / 500 tablet in 1 bottle | 31722-533-05 | Camber PharmaceuticalsIndia | 20 March 2013 |
| 12 bottle in 1 case / 1000 tablet in 1 bottle | 31722-533-10 | Camber PharmaceuticalsIndia | 20 March 2013 |
| 12 bottle in 1 case / 30 tablet in 1 bottle | 31722-533-30 | Camber PharmaceuticalsIndia | 20 March 2013 |
| 12 bottle in 1 case / 60 tablet in 1 bottle | 31722-533-60 | Camber PharmaceuticalsIndia | 20 March 2013 |
| 100 tablet, film coated in 1 bottle | 76385-123-01 | Unichem LaboratoriesIndia | 15 January 2018 |
| 500 tablet, film coated in 1 bottle | 76385-123-50 | Unichem LaboratoriesIndia | 15 January 2018 |
| 100 tablet in 1 bottle | 69306-500-01 | Doc Rx | 4 September 2025 |
| 60 tablet in 1 bottle | 69306-500-60 | Doc Rx | 4 September 2025 |
| 90 tablet in 1 bottle | 69306-500-90 | Doc Rx | 4 September 2025 |
| 100 tablet in 1 bottle | 69306-510-01 | Doc Rx | 19 March 2026 |
| 30 tablet in 1 bottle | 69306-510-03 | Doc Rx | 19 March 2026 |
| 60 tablet in 1 bottle | 69306-510-06 | Doc Rx | 19 March 2026 |
| 90 tablet in 1 bottle | 69306-510-09 | Doc Rx | 19 March 2026 |
| 100 tablet, coated in 1 bottle, plastic | 35561-212-12 | Bostal | 10 October 2018 |
| 500 tablet, coated in 1 bottle, plastic | 35561-212-13 | Bostal | 10 October 2018 |
| 100 tablet in 1 bottle | 15014-910-10 | Gentex Pharma | 22 May 2025 |
| 100 tablet, film coated in 1 bottle | 63561-0173-1 | Granulation Technology | 10 June 2025 |
| 500 tablet, film coated in 1 bottle | 63561-0173-5 | Granulation Technology | 10 June 2025 |
| 100 tablet in 1 bottle | 70868-910-10 | Key Therapeutics | 1 January 2021 |
| 90 tablet, film coated in 1 bottle | 82461-722-90 | Medcore | 31 July 2026 |
| 90 tablet in 1 bottle | 69584-611-09 | Oxford Pharmaceuticals | 15 August 2019 |
| 100 tablet in 1 bottle | 69584-611-10 | Oxford Pharmaceuticals | 15 August 2019 |
| 500 tablet in 1 bottle | 69584-611-50 | Oxford Pharmaceuticals | 15 August 2019 |
| 1000 tablet in 1 bottle | 69584-611-90 | Oxford Pharmaceuticals | 15 August 2019 |
| 100 tablet in 1 bottle | 25685-240-10 | Regimed Medical | 15 October 2026 |
| 100 tablet in 1 bottle | 43547-405-10 | Solco Healthcare | 15 December 2017 |
| 500 tablet in 1 bottle | 43547-405-50 | Solco Healthcare | 15 December 2017 |
| 100 tablet in 1 bottle | 72865-233-01 | XLCare Pharmaceuticals | 2 February 2024 |
| 500 tablet in 1 bottle | 72865-233-05 | XLCare Pharmaceuticals | 2 February 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 16 July 1957 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Methocarbamol
Clinical summary
Methocarbamol is a muscle relaxant indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. MedsAcross supplies Methocarbamol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MethocarbamolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ROBAXIN prescribing information (Hikma Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Methocarbamol 500 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.